Prognostic value of systemic immune‐inflammation index in CAD patients: Systematic review and meta‐analyses
Z Zhao, X Zhang, T Sun, X Huang, M Ma… - European Journal of …, 2024 - Wiley Online Library
Background Systemic immune‐inflammation index (SII) is a novel inflammatory marker
based on neutrophils, platelets and lymphocytes counts, which has potential prognostic …
based on neutrophils, platelets and lymphocytes counts, which has potential prognostic …
[HTML][HTML] Effects of ondansetron treatment on outcomes of critically ill patients with myocardial infarction partly through its anti-inflammatory activity
Y Boshen, Z Yuankang, L Taixi, W Zhixiang… - … Journal of Medical …, 2023 - ncbi.nlm.nih.gov
Background: Patients with myocardial infarction (MI) in intensive care units (ICU) are at high
risk of death. Whether treatment with ondansetron (OND) at an early stage plays a protective …
risk of death. Whether treatment with ondansetron (OND) at an early stage plays a protective …
Correlations Between Acute Coronary Syndrome and Novel Inflammatory Markers (Systemic Immune-Inflammation Index, Systemic Inflammation Response Index …
A Tuzimek, EA Dziedzic, J Beck… - Journal of Inflammation …, 2024 - Taylor & Francis
Purpose Type 2 diabetes mellitus (DM) is a recognized independent risk factor for both
chronic coronary syndrome (CCS) and its complication, acute coronary syndrome (ACS) …
chronic coronary syndrome (CCS) and its complication, acute coronary syndrome (ACS) …
HbA1c/C-Peptide Ratio Is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction
DG Mo, MM Wang - Angiology, 2023 - journals.sagepub.com
HbA1c/C-Peptide Ratio Is a Potential Biomarker Used to Predict No-Reflow Phenomenon in
Patients With ST-Elevation Myocardial Infarction - De-Gang Mo, Meng-Meng Wang, 2023 Skip …
Patients With ST-Elevation Myocardial Infarction - De-Gang Mo, Meng-Meng Wang, 2023 Skip …
Systemic Inflammation Index as a Novel Biomarker of No-Reflow Phenomenon in Patients With Acute Myocardial Infarction
L Wang, JJ Shan - Angiology, 2024 - journals.sagepub.com
Dear editor, We read with great interest the article entitled “Relationship Between Systemic
Inflammation Index and No-Reflow Phenomenon in Patients With ST-Segment Elevation …
Inflammation Index and No-Reflow Phenomenon in Patients With ST-Segment Elevation …
Predictive Value of Systemic Immune-Inflammatory Index in No-Reflow in Patients with ST-Segment Elevation Myocardial Infarction
JH Liu, M Zeng, Y Zhang, DG Mo - Angiology, 2023 - journals.sagepub.com
Dear editor, We read with interest the article entitled “Relationship between systemic
inflammation index and no-reflow phenomenon in patients with ST-segment elevation …
inflammation index and no-reflow phenomenon in patients with ST-segment elevation …
[PDF][PDF] IMPACT OF TYPE 2 DIABETES MELLITUS ON LOW-GRADE INFLAMMATION IN PATIENTS WITH ST-ELEVATED MYOCARDIAL INFARCTION.
MV Bielinskyi, NM Seredyuk… - Medical …, 2023 - medpers.dma.dp.ua
Impact of type 2 diabetes mellitus on low-grade inflammation in patients with ST-elevated
myocardial infarction. Bielinskyi MV, Seredyuk NM, Vytryhovskiy AI, Koroliuk VD Chronic low …
myocardial infarction. Bielinskyi MV, Seredyuk NM, Vytryhovskiy AI, Koroliuk VD Chronic low …
ASSOCIATION OF MARKERS OF LOW-GRADE INFLAMMATION IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION WITH TYPE 2 DIABETES …
МВ Бєлінський, НМ Середюк - Буковинський медичний …, 2023 - e-bmv.bsmu.edu.ua
Introduction. ST-elevated myocardial infarction (STEMI) remains a significant global health
issue and early recognition and management are crucial for reducing damage and …
issue and early recognition and management are crucial for reducing damage and …